Cargando…
Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a new pandemic that the entire world is facing since December of 2019. Increasing evidence has shown that metformin is linked to favorable outcomes in patients with COVID-19. The aim of this study was to address whether outpatient or inpatient metfo...
Autores principales: | Ma, Zhiyuan, Krishnamurthy, Mahesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949644/ https://www.ncbi.nlm.nih.gov/pubmed/36821577 http://dx.doi.org/10.1371/journal.pone.0282210 |
Ejemplares similares
-
Metformin is associated with favorable outcomes in patients with COVID-19 and type 2 diabetes mellitus
por: Ma, Zhiyuan, et al.
Publicado: (2022) -
Bacteremic sepsis leads to higher mortality when adjusting for confounders with propensity score matching
por: Mellhammar, Lisa, et al.
Publicado: (2021) -
Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis
por: Luo, Cui-Song, et al.
Publicado: (2019) -
Performance of the high-dimensional propensity score in adjusting for unmeasured confounders
por: Guertin, Jason R, et al.
Publicado: (2016) -
In-Hospital Outcomes of Inflammatory Bowel Diseases in Patients With Diabetes Mellitus: A Propensity Score Matching Analysis
por: Uwagbale, Ese, et al.
Publicado: (2021)